 SAN JOSE, Calif., March 05, 2021 GLOBE NEWSWIRE -- AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we ANPC, a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that on March 4, 2021, the Company received a letter from the Nasdaq Stock Market, Inc. Nasdaq, stating that for the last 12 consecutive business days, from February 16 to March 3, 2021, the market value of the Companys listed securities had been 50,000,000 or greater. Accordingly, Nasdaq determined that the Company has regained compliance with Nasdaq Listing Rule 5450b2A the Rule, and this matter has now been closed by Nasdaq. 